Randomized Clinical Trial to Determine the Most Appropriate Time to Start HIV Treatment in HIV and TB Coinfected Adults Being Treated for Tuberculosis.

Trial Profile

Randomized Clinical Trial to Determine the Most Appropriate Time to Start HIV Treatment in HIV and TB Coinfected Adults Being Treated for Tuberculosis.

Completed
Phase of Trial: Phase IV

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Efavirenz; Ethambutol; Isoniazid; Lamivudine; Pyrazinamide; Rifampicin; Stavudine
  • Indications HIV infections; Tuberculosis
  • Focus Therapeutic Use
  • Acronyms TB-HAART
  • Most Recent Events

    • 29 Apr 2016 Status changed from active, no longer recruiting to completed, according to the results published.
    • 29 Apr 2016 Long-term results (n=493) of pharmacokinetic parameters of efavirenz and its metabolites were published in the Journal of Clinical Pharmacology.
    • 08 Mar 2012 Results presented at the 19th Conference on Retroviruses and Opportunistic Infections.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top